BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
City Holding Co
CHCO
$1.83B
| $236K | ﹤0.01% |
4,088
+2,761
| +208% | +$159K |
|
1952
Standard Motor Products
SMP
$889M
| $235K | ﹤0.01% |
5,273
+4,063
| +336% | +$181K |
|
1953
WaFd
WAFD
$2.46B
| $235K | ﹤0.01% |
11,285
+1,726
| +18% | +$36K |
|
1954
Myriad Genetics
MYGN
$674M
| $235K | ﹤0.01% |
18,008
+4,812
| +36% | +$62.7K |
|
1955
Intellia Therapeutics
NTLA
$1.23B
| $234K | ﹤0.01% |
11,779
+5,566
| +90% | +$111K |
|
|
ZGNX
1956
DELISTED
Zogenix, Inc.
ZGNX
| $234K | ﹤0.01% |
13,057
+10,271
| +369% | +$184K |
|
1957
e.l.f. Beauty
ELF
$7.67B
| $234K | ﹤0.01% |
12,726
+7,655
| +151% | +$141K |
|
1958
Scorpio Tankers
STNG
$2.99B
| $232K | ﹤0.01% |
21,000
+12,355
| +143% | +$137K |
|
1959
TriMas Corp
TRS
$1.59B
| $232K | ﹤0.01% |
10,193
+7,420
| +268% | +$169K |
|
|
VNET
1960
VNET Group
VNET
$2.57B
| $232K | ﹤0.01% |
10,030
-10,785
| -52% | -$250K |
|
1961
Canadian Natural Resources
CNQ
$64.9B
| $232K | ﹤0.01% |
29,546
+2,818
| +11% | +$22.1K |
|
1962
Travere Therapeutics
TVTX
$2.09B
| $231K | ﹤0.01% |
12,512
+8,961
| +252% | +$165K |
|
1963
eXp World Holdings
EXPI
$1.75B
| $231K | ﹤0.01% |
11,430
+9,432
| +472% | +$190K |
|
1964
Employers Holdings
EIG
$983M
| $230K | ﹤0.01% |
7,613
+4,781
| +169% | +$145K |
|
1965
Nokia
NOK
$24.3B
| $230K | ﹤0.01% |
58,797
-159,878
| -73% | -$625K |
|
1966
Acadia Realty Trust
AKR
$2.64B
| $230K | ﹤0.01% |
21,876
+7,544
| +53% | +$79.2K |
|
|
INVX
1967
Innovex International, Inc.
INVX
$1.14B
| $229K | ﹤0.01% |
9,248
+5,800
| +168% | +$144K |
|
|
GNMK
1968
DELISTED
GenMark Diagnostics, Inc
GNMK
| $229K | ﹤0.01% |
16,107
-72,443
| -82% | -$1.03M |
|
1969
Domo
DOMO
$701M
| $228K | ﹤0.01% |
5,955
+5,000
| +524% | +$192K |
|
|
QVCGA
1970
QVC Group, Inc. Series A Common Stock
QVCGA
$92M
| $228K | ﹤0.01% |
634
-499
| -44% | -$179K |
|
1971
Upland Software
UPLD
$71.6M
| $228K | ﹤0.01% |
6,035
+5,197
| +620% | +$196K |
|
1972
Heartland Express
HTLD
$656M
| $227K | ﹤0.01% |
12,215
+8,354
| +216% | +$155K |
|
1973
AZZ Inc
AZZ
$3.52B
| $226K | ﹤0.01% |
6,630
+4,490
| +210% | +$153K |
|
1974
Core Laboratories
CLB
$581M
| $226K | ﹤0.01% |
14,789
-20,823
| -58% | -$318K |
|
1975
Hope Bancorp
HOPE
$1.4B
| $226K | ﹤0.01% |
29,737
+19,764
| +198% | +$150K |
|